JEAN-MARCEL CIET
DISTRIBUTION
Founded in 1999 as a small venture with limited profitability , Ceva Animal Health has grown over the past quarter of a century to become one of the largest animal health companies in the world .
The organisation has strategically built itself into a highly-innovative enterprise , addressing the health needs of diverse animal populations . From livestock to companion animals and even wildlife , its approach is comprehensive and forward-thinking .
Ceva ’ s focus has , historically , been on preventive medicine , with vaccines making up around half of its overall sales volume . Notably , the business has pioneered vector vaccines for poultry , establishing a significant market leadership .
“ That ’ s been our historical stronghold but now we have a large portfolio across different species ,” explains Jean-Marcel Ciet , Digital , Smart Solutions and Supply Chain EVP .
“ We ’ ve been able to build and transform the business really progressively .”
With a global footprint comprising 21 R & S centres and more than 30 industrial sites worldwide , Ceva now transcends its French origins .
“ We ’ re very proud of our roots in South West France , but the French market is a small part of our business ,” Jean-Marcel adds . “ We are very much a worldwide company .”
JEAN-MARCEL CIET
TITLE : DIGITAL , SMART SOLUTIONS AND SUPPLY CHAIN EVP
COMPANY : CEVA ANIMAL HEALTH
INDUSTRY : PHARMACEUTICALS / MANUFACTURING
Jean-Marcel Ciet serves as Digital , Smart Solutions and Supply Chain EVP at Ceva Animal Health . Over the years he has amassed a wealth of experience in industries including healthcare , consulting , telecommunications and finance .
Keeping distribution in-house Ceva Animal Health ’ s size means it must inevitably look after a complex and evergrowing logistics and distribution network .
In October , the company inaugurated its new , state-of-the-art European distribution centre in Montpon -Ménestérol , France , about 45 miles east of Bordeaux .
The facility is designed to store products developed by Ceva in Europe , supporting three main pharmaceutical factories in France and another major factory in Hungary specialising in bio -vaccines , before shipping them all over the world .
“ We saw this as an opportunity to show our commitment to innovation , including in the supply chain ,” Jean-Marcel Ciet continues .
116 March 2025